(1 - 26 von 33
)
Celldex Announces Acceptance of CDX Late-Breaking Poster...
www.globenewswire.com
Marcus Maurer, Professor of Dermatology and Allergy and Director of Research at the Department of Dermatology and Allergy at the Allergie- ...
Dupilumab improves urticaria activity and QoL in patients with ...Medical Dialogues
medicaldialogues.in
vor 2 Tagen — Marcus Maurer, Charite-Universitatsmedizin Berlin, Germany, and colleagues to evaluate dupilumab's effectiveness and safety in treating ... › ... › Dermatology News
Remibrutinib confers fast symptom improvement in chronic ...Healio
www.healio.com
vor 7 Tagen — ... Marcus Maurer, MD, professor of dermatology and allergy, executive director of the Institute of Allergology at Charité – Universitätsmedizin ...
Allakos Announces Positive Phase 1 Results with AK002 in Indolent...
investor.allakos.com
Marcus Maurer , M.D., Professor of Dermatology and Allergy at Charité University in Berlin . Data for the combined cohorts are presented below; ...
sortiert nach Relevanz / Datum